NFKB1 and diffuse large B-cell lymphoma: Our findings elucidate the role of TNFRSF1A<sup>+</sup> TAMs in driving DLBCL progression, highlight the TNFRSF1A/NF-κB/BAFF axis as a vulnerability in the DLBCL microenvironment, and propose curcumin as a viable therapeutic strategy to disrupt this supportive microenvironment.